Literature DB >> 16331129

Creatine supplementation reduces muscle inosine monophosphate during endurance exercise in humans.

Glenn K McConell1, Joanna Shinewell, Terry J Stephens, Christos G Stathis, Benedict J Canny, Rodney J Snow.   

Abstract

INTRODUCTION: Creatine (Cr) supplementation has been shown to attenuate increases in plasma ammonia and hypoxanthine during intense endurance exercise lasting 1 h, suggesting that Cr supplementation may improve muscle energy balance (matching of ATP resynthesis to ATP demand) during such exercise. We hypothesized that Cr supplementation would improve muscle energy balance (as assessed by muscle inosine monophosphate (IMP) accumulation) during intense endurance exercise.
METHODS: Seven well-trained men completed two experimental trials involving approximately 1 h of intense endurance exercise (cycling 45 min at 78+/-1% & OV0312;O2 peak followed by completion of 251+/-6 kJ as quickly as possible (performance ride)). Subjects ingested approximately 42 g.d dextrose for 5 d before the first experimental trial (CON), then approximately 21 g Cr monohydrate plus approximately 21 g.d dextrose for 5 d before the second experimental trial (CREAT). Trials were ordered because of the long washout time for Cr. Subjects were blinded to the order of the trials.
RESULTS: Creatine supplementation significantly (P< 0.05) increased muscle total Cr (resting values: CREAT: 138.1+/-7.9; CON: 117.7+/- 6.5 mmol.kg dm). No difference was seen between treatments in any measured muscle or blood metabolite after the first 45 min of exercise. Despite the performance ride completion time being similar in the two treatments ( approximately 13.5 min, approximately 86% &amp; OV0312;O2 peak), IMP at the end of the performance ride was significantly (P<0.05) lower in CREAT than in CON (CREAT: 1.2+/- 0.6; CON: 2.0+/- 0.7 mmol.kg dm).
CONCLUSION: Raising muscle total Cr content before exercise appears to improve the ability of the muscle to maintain energy balance during intense aerobic exercise, but not during more moderate exercise intensities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331129     DOI: 10.1249/01.mss.0000179096.03129.a4

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Fucoidan supplementation improves exercise performance and exhibits anti-fatigue action in mice.

Authors:  Yi-Ming Chen; Yi-Hsin Tsai; Tsung-Yu Tsai; Yen-Shuo Chiu; Li Wei; Wen-Chyuan Chen; Chi-Chang Huang
Journal:  Nutrients       Date:  2014-12-31       Impact factor: 5.717

2.  The effects of four weeks of creatine supplementation and high-intensity interval training on cardiorespiratory fitness: a randomized controlled trial.

Authors:  Jennifer L Graef; Abbie E Smith; Kristina L Kendall; David H Fukuda; Jordan R Moon; Travis W Beck; Joel T Cramer; Jeffrey R Stout
Journal:  J Int Soc Sports Nutr       Date:  2009-11-12       Impact factor: 5.150

3.  The influence of different diets on metabolism and atherosclerosis processes-A porcine model: Blood serum, urine and tissues 1H NMR metabolomics targeted analysis.

Authors:  Adam Zabek; Robert Paslawski; Urszula Paslawska; Wojciech Wojtowicz; Katarzyna Drozdz; Sergio Polakof; Marzena Podhorska; Piotr Dziegiel; Piotr Mlynarz; Andrzej Szuba
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

4.  Effect of dietary arginine to lysine ratios on productive performance, meat quality, plasma and muscle metabolomics profile in fast-growing broiler chickens.

Authors:  Marco Zampiga; Luca Laghi; Massimiliano Petracci; Chenglin Zhu; Adele Meluzzi; Sami Dridi; Federico Sirri
Journal:  J Anim Sci Biotechnol       Date:  2018-11-08

5.  Effects of Oral Creatine Supplementation on Power Output during Repeated Treadmill Sprinting.

Authors:  Gregory C Bogdanis; Mary E Nevill; George Aphamis; Pinelopi S Stavrinou; David G Jenkins; Christoforos D Giannaki; Henryk K A Lakomy; Clyde Williams
Journal:  Nutrients       Date:  2022-03-08       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.